Anal Cancer Information

Anal Cancer

Anal cancer is a condition in which malignant (cancerous) cells divide and grow uncontrollably in the tissues of the anus and anal canal. Located at the end of the large intestine, below the rectum, this is the region of the body through which solid waste is eliminated. Anal cancer is relatively rare – far less common than cancers of the colon or rectum. It is most common among women in their early 60s, though men who have same-sex partners also have a high risk of developing the condition. Anal cancer has a significant link to the human papilloma virus (HPV), though other risk factors have been identified as well.

Most anal cancers develop in the mucosa – the inner lining of the anal canal, an area roughly an inch and a half long that connects the rectum with the anal verge (the place where the anal canal meets the external skin of the anus). However, many different kinds of tumors can develop in the anus and anal canal, and not all of them are malignant. Benign tumors (noncancerous), however, can develop into cancer over time.

Our Approach

Moffitt Cancer Center’s Gastrointestinal Oncology Program takes a unique approach to treating anal cancer by assembling a multispecialty team of experts that meets weekly to develop and monitor the progress of an individualized treatment plan for each patient. This collaborative team includes:

  • Surgeons
  • Medical oncologists
  • Radiation oncologists
  • Interventional oncologists
  • Endoscopy specialists

Each of these experts brings a highly specialized medical understanding to the diagnostic, treatment and patient care process. Our oncologists have extensive experience in treating anal cancer and know which treatment strategies work best given the health and age of the patient, the dynamics of the individual tumor and other variables. Plus, our researchers work diligently each day through our vigorous clinical trials program to find new, more effective treatments to help overcome anal cancer and prevent it from returning. For these reasons and more, Moffitt has been named a Comprehensive Cancer Center by the National Cancer Institute – the only cancer center based in Florida to have received this designation. When you entrust your cancer treatment to the experts at Moffitt, you know you are in good hands.

Contact Moffitt Cancer Center by calling 1-888-663-3488 or filling out a new patient registration form to learn more about anal cancer and the ways in which we can help you fight it. No referral is required to meet with our oncologists specializing in anal cancer.

Basal Cell Carcinoma Treatment Information

 

Basal cell carcinoma is an extremely common type of nonmelanoma skin cancer. It is also responsible for the majority of cancer diagnoses in the United States. As the name suggests, this malignancy originates in the basal cells, which are responsible for producing new skin cells as old cells die off. Unlike other types of cancer, basal cell carcinoma rarely spreads beyond the area in which it originally develops.

Our Approach

At Moffitt Cancer Center, we take an innovative, multispecialty approach to treating basal cell carcinoma. In our Cutaneous Oncology Program, an experienced team of oncologists (all of whom focus exclusively on the treatment of skin cancer) will review each patient’s needs to determine which therapies would be most suitable. After considering the cellular makeup of the cancer, the patient’s ability to tolerate certain treatments and a number of other unique factors, our tumor board may recommend:

  • Surgery – Most basal cell carcinomas can be surgically managed through a traditional excision, but our experienced skin cancer surgeons can also perform more complex operations (e.g. a lymph node resection or a graft reconstruction) if necessary.
  • Radiation therapy – Moffitt’s radiation oncologists can devise a treatment plan that delivers the maximum safe dose of ionizing radiation to a cancerous lesion, while minimizing exposure to nearby healthy skin.
  • Immunotherapy – Mainly available through clinical trials, these therapies target various molecules in the body (such as the protein interleukin-2) to induce an immune response to the basal cell carcinoma.

Several other treatments, such as adoptive cell therapy and intralesional therapy, are also available through our robust clinical trial program. As a National Cancer Institute-designated Comprehensive Cancer Center, we are at the forefront of groundbreaking research that not only benefits our patients, but every individual who has been diagnosed with basal cell carcinoma. Plus, these trials allow us to provide our patients with access to the widest possible range of therapies in one convenient location. 

To learn more about basal cell carcinoma treatment at Moffitt Cancer Center, call 1-888-663-3488 or complete a new patient registration form. No referral is necessary.

Bladder Cancer Treatment Information

Bladder cancer is the result of cells in the bladder changing and growing rapidly and uncontrollably. The mass that forms as a result of these cellular changes, called a tumor, can be harmless (benign), which means it is not likely to spread to other parts of the body. However, some tumors are deemed likely to spread (malignant) and cause significant health issues if left untreated. This condition is what a physician may describe as bladder cancer.

Our Approach

At Moffitt Cancer Center, the highly acclaimed multispecialty team of experts in our Genitourinary Oncology Program assesses every patient on a case-by-case basis at a collaborative tumor board discussion. This individualized approach to diagnosing and treating bladder cancer puts each patient center stage, where he or she receives the most comprehensive evaluations and treatment recommendations. It’s just one of the many ways in which Moffitt has distinguished itself as one of the best bladder cancer hospitals. At Moffitt’s Genitourinary Oncology Clinic:

  • Each patient receives treatment plans that are precisely focused on the unique characteristics of his or her bladder cancer – an approach which results in more effective treatment, higher survival rates and improved quality of life.
  • We use state-of-the-art technology in our surgical treatments, with the assistance of robotics and advanced laparoscopies, in order to keep procedures as minimally invasive as possible.
  • We are constantly developing new therapies for bladder cancer and other urologic cancers, and are always striving to achieve the highest standard of cancer treatment excellence.

Moffitt is a National Cancer Institute-designated Comprehensive Cancer Center – a testament to our extensive research efforts and our robust clinical trials, which include cancer treatments unavailable anywhere else. Our team of bladder cancer specialists is comprised of renowned experts in all components of cancer research, from new drug studies to developing new surgical techniques and treatments. In fact, from a surgical perspective, we say with confidence that if Moffitt can’t do it, it probably can’t be done.

Contact Moffitt Cancer Center at 1-888-663-3488 or by completing a new patient registration form.

 

Helpful Links:

Brain Cancer Treatment Options

Brain cancer can refer to cancer that starts in the brain, or cancer that starts elsewhere in the body and eventually metastasizes (spreads) to the brain through the bloodstream. If a tumor originates in the brain tissue, it is known as a primary brain tumor; if it originates elsewhere in the body and spreads to the brain, it is known as a metastatic brain tumor.

Metastatic tumors are much more common than primary tumors. Cancers of the lungs, breasts and kidneys are especially likely to metastasize to the brain. According to the American Association of Neurological Surgeons, approximately one out of every four cancer patients will eventually experience a brain metastasis. 

Our Approach 

At Moffitt Cancer Center, we provide advanced, multispecialty treatment to patients with primary and metastatic brain cancers. Unlike other cancer centers, where brain cancer may be just one small area of focus, our specialized Neuro-Oncology Program focuses exclusively on skull base, spine and brain tumor treatment.

Our oncologists have experience diagnosing and treating many different types of brain cancer, including:

  • Glioblastomas
  • Astrocytomas
  • Mixed gliomas
  • Oligodendrogliomas
  • Ependymomas
  • Pituitary adenomas
  • Schwannomas
  • Craniopharyngiomas
  • Meningiomas
  • Medullioblastomas 

Our team also specializes in the management of other brain-related conditions, including central nervous system (CNS) lymphoma, meningeal carcinoma and neurofibromatosis. 

Our multispecialty brain cancer team is made up of not only neurosurgeons, radiation oncologists and medical oncologists, but also highly specialized neurologists, neuroradiologists, neuropathologists and neuropsychologists, all of whom work together on a tumor board to improve each patient’s prognosis and quality of life. Throughout the course of a patient’s treatment, the tumor board will evaluate the patient’s progress in light of the newest research findings to make evidence-based recommendations. 

Moffitt is a founding and active member of the National Cancer Institute’s Adult Brain Tumor Consortium – one of just 15 in the United States. At Moffitt, patients can access a complete range of brain cancer treatments, including molecular therapy, stereotactic radiosurgery and chemotherapy, all in one convenient location. Clinical trials, which allow patients to receive the most innovative therapies under the care of a dedicated treatment team, are also available at Moffitt.

No referral is required to come to Moffitt Cancer Center. To schedule an appointment, call 1-888-663-3488 or fill out our new patient registration form.

 

Helpful Links:

Breast Cancer Treatment Information

Breast cancer develops as a result of the uncontrolled growth of abnormal breast cells. While healthy breast cells are able to continually renew themselves in an orderly fashion, abnormal cells may divide haphazardly, without control or order. The extra cells created can form malignant, or cancerous, tumors which, if left untreated, can spread to other parts of the body. There are many different types of breast cancer. The most common are invasive ductal cancer, which begins in the duct cells, and invasive lobular cancer, which begins in a lobule, where milk-producing glands are present. A patient facing a breast cancer concern likely has many questions. Choosing the right cancer center for consultation, diagnosis and support is the most important step toward achieving lasting, positive results.  

Our Approach    

At Moffitt Cancer Center, the Don & Erika Wallace Comprehensive Breast Program boasts a multispecialty, full-service clinic that offers the latest in preventive care and support for all breast-related conditions. In a single location, our breast clinic provides our patients with all of the services they need from a cohesive team of doctors and other experts who specialize in breast cancer, including:    

  • Fellowship-trained surgeons
  • Medical oncologists
  • Pathologists
  • Fellowship-trained radiologists
  • Radiation oncologists
  • Plastic surgeons and breast reconstruction experts
  • Social workers
  • Fertility preservation specialists
  • Genetic testing and counseling specialists  

During a weekly interactive session, or tumor board review, these experts meet to discuss each new patient’s course of treatment. They work together to create highly individualized care for our patients in order to offer them the best chance at beating cancer. Whether the initial concern is an abnormal mammogram result, a family history of breast cancer, a breast lump or another symptom, patients benefit from our state-of-the-art diagnostic and treatment options, which include advanced INTRABEAM® radiation treatment, tomosynthesis 3D mammography, ABUS (Automated Breast Ultrasound System) and ultrasound-guided core needle biopsy. Best of all, breast cancer patients do not need a referral to benefit from our services and support.   

As a pioneer in cancer research, Moffitt is proud to be the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida. Our patients benefit from a broad range of cutting-edge clinical trials and new therapies for individuals with breast cancer. Each year, we treat more than 1,000 newly diagnosed breast cancer patients, as well as hundreds more who choose Moffitt for treatment when they have a recurrence. Our breast cancer survival rates are above the national averages, and we are proud that our treatment and support can provide our patients with an enhanced quality of life.  

To learn more about our services and how to prepare for your appointment, please call 1-888-663-3488, or you can request an appointment online.    

Helpful links: